Delisted 1 Sep 2026, acquired. Prices shown are the last trade and are not live.

Crinetics Pharmaceuticals, Inc. (CRNX) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for CRNX. 13F holdings as of 2026-06-30.

In 13F filings for the quarter ended June 30, 2026, 256 institutions reported holding CRNX, with 123.6 million shares worth $4.6 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
FMR15,840,219$593MINCREASED
Vanguard10,491,179$393MINCREASED
BlackRock9,758,938$365MINCREASED
Farallon Capital Management8,989,098$336MINCREASED
T. Rowe Price8,222,969$308MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Wendell Wierenga (Director)SELL9,730$478K2026-09-01
Wendell Wierenga (Director)SELL10,350$545K2026-09-01
Wendell Wierenga (Director)SELL12,500$504K2026-09-01
Wendell Wierenga (Director)SELL17,500$1M2026-09-01
Wendell Wierenga (Director)SELL17,500$1M2026-09-01

Recent Congressional Trades

MemberTypeAmountDate
Gilbert Cisneros (Democrat)SALE$15,001 - $50,0002026-07-30
Gilbert Cisneros (Democrat)SALE$15,001 - $50,0002026-07-29

Full institutional holdings, insider history, and congressional trades for Crinetics Pharmaceuticals, Inc. on SentiSense.